13
total announcements
GKB.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 27 Oct 2026
Market Cap
₹30 Cr
P/E (TTM)
9.4
EPS (TTM)
₹6.43
52W Low
₹55.01
52W High
₹88.40
Dividend Yield
0.00%
Beta
0.47
Price / Book
0.6
Debt / Equity
21.2
Revenue (TTM)
₹150 Cr
Gross Margin
28.14%
Operating Margin
5.77%
GKB Ophthalmics Ltd
GKB Ophthalmics Ltd has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, confirming the dematerialization of securities and listing on stock exchanges.
GKB Ophthalmics Ltd
GKB Ophthalmics Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of its financial results for the quarter ended September 30, 2026. This means that all promoters, directors, and designated persons of the company, along with their immediate relatives, are prohibited from entering into any transaction involving the trading of the company's shares during this period.
GKB Ophthalmics Ltd
GKB Ophthalmics Ltd has submitted the minutes of its 44th Annual General Meeting (AGM) held on August 25, 2026, as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
GKB Ophthalmics Ltd
GKB Ophthalmics Ltd held its 44th Annual General Meeting on August 25, 2026, where all resolutions were passed with requisite majority. The meeting was attended by 32 shareholders, including 4 promoters and 28 public shareholders. The resolutions included the adoption of standalone and consolidated financial statements, reappointment of Mr. Vikram Gupta, and other ordinary resolutions.
GKB Ophthalmics Ltd
GKB Ophthalmics Ltd held its 44th Annual General Meeting on August 25, 2026, where the company's performance for the financial year 2025-26 was discussed. The meeting approved various resolutions, including the re-appointment of directors, related party transactions, and office or place of profit in a subsidiary company.
GKB Ophthalmics Ltd
GKB Ophthalmics Ltd has announced unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with total income from operations at ₹75.12 lakhs and net profit for the period at ₹45.69 lakhs.
GKB Ophthalmics Ltd
GKB Ophthalmics Ltd has released its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, showing revenue from operations at Rs. 539.69 lakhs, other income at Rs. 47.35 lakhs, and total income at Rs. 687.71 lakhs. The company's expenses include cost of materials consumed, employee benefits expense, finance costs, depreciation and amortization expense, and other expenses. The profit before exceptional items is Rs. 173.94 lakhs, and the profit before tax is Rs. 73.91 lakhs. The company has also disclosed exceptional items of Rs. 149.4 lakhs.
GKB Ophthalmics Ltd
GKB Ophthalmics Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company has reported a write-off of AED 1,69,325.58 due to the closure of its subsidiary, Prime Ophthalmics Products PTY Limited. The company has also filed a writ petition against the recovery proceedings initiated by the Mamlatdar of Bardez Taluka.
GKB Ophthalmics Ltd
GKB Ophthalmics Ltd. has published a public notice in The Times of India (Goa Edition) and Pudhari (Marathi) regarding the completion of dispatch of notice of annual general meeting together with annual report for the financial year 2025-26. The notice also mentions the proposed Deed of Release/Relinquishment in favor of Mr. Abhishek Jaikumar Jain, relinquishing all rights, title, interest, and share in Flat Nos. 703 & 704, Building No. 5, Shanti Garden, Sector-3, Mira Road (East), Thane.
GKB Ophthalmics Ltd
GKB Ophthalmics Ltd has sent a letter to shareholders whose email addresses are not registered with the company or its registrar, providing a web link to access the Annual Report for FY 2025-26. The company also reminds shareholders to update their KYC details and dematerialize physical securities.
GKB Ophthalmics Ltd
GKB Ophthalmics Ltd has announced a book closure from August 19 to August 25, 2026, for its 44th Annual General Meeting, with no dividend proposed for the year 2025-26.
GKB Ophthalmics Ltd
GKB Ophthalmics Ltd has submitted its Annual Report for the financial year 2025-26, along with the Notice of the 44th Annual General Meeting. The report is available on the company's website and has been sent electronically to members whose email addresses are registered with the company.
GKB Ophthalmics Ltd
GKB Ophthalmics Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 to consider and approve the Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.